Business
PAVmed Digital Health Subsidiary Veris Health's Veris Cancer Care Platform™ Goes Live
Remote patient monitoring of first cohort of cancer patients using VerisBox™ connected devices and Veris CCP smartphone app initiated Cancer care team
About this update from Pavmed Inc.
[{"type":"text","content":"Remote patient monitoring of first cohort of cancer patients using VerisBox™ connected devices and Veris CCP smartphone app initiated\nCancer care team utilizing physiologic data and patient reported symptoms delivered to cloud-based Veris CCP clinician portal for real-time optimized personalized care\nNEW YORK, Feb. 28, 2023 /PRNewswire/ -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (\"PAVmed\"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, and its majority-owned digital health subsidiary Veris Health Inc. (\"Veris\"), today announced that the Veris Cancer Care Platform™ (Veris CCP), designed to enhance personalized cancer care through remote patient monitoring (RPM), is now live following successful onboarding of the first cohort of cancer patients and their clinicians.\n\n \n \n \n \n \n \n\n \nEnrolled patients received a VerisBox™ and were then successfully trained to use its Veris-branded Bluetooth-enabled connected health care devices to transmit real-time physiologic data to the cloud-based Veris CCP clinician portal via an embedded cellular connection. The patients also began reporting symptoms, as well as general health and quality of life parameters, to their cancer care team through the Veris CCP patient smartphone app (which allows caretakers and loved ones to follow along the patient's journey). The app is now available on the Apple App Store and Google Play. The cloud-based clinician portal was integrated into the oncology practice's information technology systems and the cancer care team was trained to use the portal to review physiologic and clinical data to deliver enhanced personalized care, allowing the practice to start billing for these RPM services on a monthly basis.\n\"We are very excited that the promise of enhancing personalized cancer care through RPM using our state-of-the-art digital health platform, Veris CCP, has become a reality for cancer patients and their clinicians,\" said Lishan Aklog, M.D., PAVmed's Chairman & Chief Executive Officer and Veris' Executive Chairman. \"Our team together with the New Jersey Cancer Care team flawlessly executed the required technical integration and onboarding processes. Early reports of our platform already having a real impact on clinical care are very gratifying. Our software-as-a-...